Tokyo Tape
Sign in
← Cytori Cell Research Institute

Quarterly report · Q3

3750.TEDINET S100Q6BK
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥1.7bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥1.3bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.0bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income−¥516m2022-04-01 → 2022-12-31Cons.Operating income
Operating income−¥296m2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income−¥602m2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income−¥418m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥271m2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax−¥710m2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥41m2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)−¥723m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥78m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥61m2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income−¥723m2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥62m2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥14.1bnat 2022-12-31Cons.Assets
Total assets¥16.0bnat 2022-03-31Cons.Assets
Total assets¥16.0bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥11.1bnat 2022-12-31Cons.Liabilities
Total liabilities¥12.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.0bnat 2022-12-31Cons.Net assets
Net assets / equity¥3.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.8bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥776mat 2022-12-31Cons.Cash and deposits
Cash and deposits¥852mat 2022-03-31Cons.Cash and deposits
EPS (basic)¥-80.952022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-18.092022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.792021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥6.972021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.82021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥6.812021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio19.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio21.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio22.4%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥116m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-12-31¥128m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-12-31¥128m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-12-31−¥224m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-12-31−¥176m
—segment totalrevenue2022-04-01 → 2022-12-31¥1.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥1.7bn
—segment totalsegment profit2022-04-01 → 2022-12-31−¥400m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31−¥110m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue2021-04-01 → 2021-12-31¥170m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue external2021-04-01 → 2021-12-31¥170m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentsegment profit2021-04-01 → 2021-12-31−¥133m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue2021-04-01 → 2021-12-31¥870m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue external2021-04-01 → 2021-12-31¥870m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentsegment profit2021-04-01 → 2021-12-31−¥53m
—segment totalrevenue2021-04-01 → 2021-12-31¥1.0bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥1.0bn
—segment totalsegment profit2021-04-01 → 2021-12-31−¥186m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 323
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant11294823000JPY
Noncurrent liabilitiesCurrentQuarterInstant10443811000JPY
LiabilitiesPrior1YearInstant12290313000JPY
LiabilitiesCurrentQuarterInstant11083750000JPY
Capital stockPrior1YearInstant100000000JPY
Capital stockCurrentQuarterInstant100000000JPY
Capital surplusPrior1YearInstant2939268000JPY
Capital surplusCurrentQuarterInstant2939268000JPY
Retained earningsPrior1YearInstant462800000JPY
Retained earningsCurrentQuarterInstant-259780000JPY
Treasury stockPrior1YearInstant-982000JPY
Treasury stockCurrentQuarterInstant-1183000JPY
Shareholders equityPrior1YearInstant3501085000JPY
Shareholders equityCurrentQuarterInstant2778304000JPY
Valuation difference on available for sale securitiesPrior1YearInstant67000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant102000JPY
Valuation and translation adjustmentsPrior1YearInstant67000JPY
Valuation and translation adjustmentsCurrentQuarterInstant102000JPY
Subscription rights to sharesPrior1YearInstant211501000JPY
Subscription rights to sharesCurrentQuarterInstant211501000JPY
Non controlling interestsPrior1YearInstant3798000JPY
Non controlling interestsCurrentQuarterInstant3895000JPY
Net assetsPrior1YearInstant3716452000JPY
Net assetsCurrentQuarterInstant2993804000JPY
Liabilities and net assetsPrior1YearInstant16006766000JPY
Liabilities and net assetsCurrentQuarterInstant14077555000JPY
Net salesPrior1YTDDuration1039719000JPY
Net salesCurrentYTDDuration1651836000JPY
Cost of salesPrior1YTDDuration414483000JPY
Cost of salesCurrentYTDDuration737921000JPY
Gross profitPrior1YTDDuration625236000JPY
Gross profitCurrentYTDDuration913914000JPY
Selling general and administrative expensesPrior1YTDDuration921066000JPY
Selling general and administrative expensesCurrentYTDDuration1429743000JPY
Operating incomePrior1YTDDuration-295829000JPY
Operating incomeCurrentYTDDuration-515828000JPY
Subsidy income noi bountyPrior1YTDDuration71587000JPY
Subsidy income noi bountyCurrentYTDDuration22758000JPY
Other noiPrior1YTDDuration25144000JPY
Other noiCurrentYTDDuration8898000JPY
Non operating incomePrior1YTDDuration96732000JPY
Non operating incomeCurrentYTDDuration31657000JPY
Interest expenses noePrior1YTDDuration67841000JPY
Interest expenses noeCurrentYTDDuration92478000JPY
Arrangement fee noePrior1YTDDuration－JPY
Arrangement fee noeCurrentYTDDuration25000000JPY
Other noePrior1YTDDuration4036000JPY
Other noeCurrentYTDDuration177000JPY
Non operating expensesPrior1YTDDuration71877000JPY
Non operating expensesCurrentYTDDuration117656000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass